Clinical trial
DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting
NCT00741065 is registered in ClinicalTrials.gov with Cardiac Regeneration Technologies, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- DESWT-Pilot Study on the Safety of Myocardial Regeneration by Direct Epicardial Shock Wave Therapy in Combination With Coronary Artery Bypass Grafting
- Lead sponsor
- Cardiac Regeneration Technologies, LLC
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 30, 2008
- Completion date
- February 28, 2010
- Enrollment
- 10 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
reduced left ventricular function defined as lvef < 50%, regional left ventricular wall motion abnormalities